Dyax, taiba ME partner on angiodema treatment

http - June 5th, 2012

Dyax Corp. (NASDAQ: DYAX) of Burlington said today that it has given exclusive distribution rights to taiba ME to use Dyax’s Kalbitor to treat hereditary angioedema in the Middle East

News Sources

Related news

Other news on this day

IRIB News - June 5th, 2012
IRIB News - June 5th, 2012